N = 647 | |
---|---|
Age (years) | 54.4 (44–64) |
BMI | 25.7 (21.1–29.4) |
Hormonal statusa | |
Menopausal | 355 (54.9) |
Childbearing | 282 (43.6) |
Parity | 2.7 (1–3) |
Pathologic type | |
Squamous cell | 530 (81.9) |
Adenocarcionma | 88 (13.6) |
Other | 29 (4.5) |
FIGO stagea | |
IB2 | 86 (13.3) |
IIA | 58 (9.0) |
IIB | 359 (55.5) |
III | 69 (10.7) |
IV | 66 (10.2) |
Pre-operative imaging | |
CT-scan | 276 (42.7) |
PET-CT | 371 (57.3) |
Tumor size on MRI | |
< 40 mm | 194 (30.0) |
40–60 mm | 278 (43.0) |
> 60 mm | 112 (17.3) |
Unknown | 63 (9.7) |
Concomitant chemoradiation (CRT) | 647 (100) |
Intracavitary brachytherapy | 343 (53.0) |
RCC Boost in paraaortic lymph nodes | 153 (23.6) |
Completion surgery after CRT | 290 (44.8) |